US Patent 9512164 Oligonucleotide end caps

Patent 9512164 was granted and assigned to Alnylam Pharmaceuticals on December, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Alnylam Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9512164

Date of Patent

December 6, 2016

Patent Application Number

13382353

Date Filed

July 7, 2010

Patent Citations Received

‌

US Patent 11879125 GalNAc compositions for improving siRNA bioavailability

Patent Primary Examiner

‌

Lisa J Hobbs

Patent abstract

Modified nucleic acids are described herein, including pharmaceutical compositions comprising the modified nucleic acids, and methods of using the modified nucleic acids.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9512164 Oligonucleotide end caps

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API